Adult respiratory distress syndrome. Pathogenesis and therapy of acute lung injury;AKUT RESPIRATORISK DISTRESS-SYNDROM. PATOGENESE OG TERAPI AF AKUT LUNGESVIGT

Ugeskrift for Laeger

Volumn 158, Issue 25, 1996, Pages 3593-3600

  Welling, Karen Lise Kobberø ^a,b  

^a NONE   (Denmark)

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CYTOKINE; FREE RADICAL; ICOSANOID; IMMUNOMODULATING AGENT; INOTROPIC AGENT; LUNG SURFACTANT; NITRIC OXIDE; PROSTACYCLIN; PROSTAGLANDIN E1;

ADULT RESPIRATORY DISTRESS SYNDROME; CLINICAL FEATURE; HUMAN; LUNG INJURY; MORTALITY; OXYGENATION; PATHOGENESIS; PULMONARY HYPERTENSION; REVIEW; SYMPTOMATOLOGY;

EID: 0029938296     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L et al. Report of the American-European Consensus Conference on ARDS. Am J Respir Crit Care Med 1994; 149: 818-24.
2. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967; II: 319-23.
3. Suchyta MR, Clemmer TP, Elliott CG, Orme JF Jr, Weaver LK, The adult respiratory distress syndrome: a report of survival and modifying factors. Chest 1992; 101: 1074-9.
4. Goris RJA. Sepsis and multiple organ failure: the result of whole body inflammation I: Faist E, Meakins J, Shildberg FW, eds. Host defence dysfunction in trauma, shock, and sepsis. Berlin: Springer-Verlag, 1993: 161-70.
5. Schuster TP. What is the mortality of ARDS? I: Vincent JL, ed. Yearbook of intensive care and emergency medicine. Berlin: Springer-Verlag, 1995; 15: 59-68.
6. Pepe PE, Potkin RT, Holtman-Reus D, Hudson LD, Carrico CJ. Clinical predictors of the adult respiratory distress syndrome. Am J Surg 1982; 144: 124-8.
7. Beale R, Grover ER, Smithies M, Bihari D. Acute respiratory distress syndrome ("ARDS"): no more than severe acute lung injury? BMJ 1993; 307: 1335-9.
8. National Heart and Lung Institutes. Respiratory diseases. Task force report on problems, research approaches, needs. Washington, DC: US Government Printing Office, 1972: 167-80 (DHEW publication NIH 74-432).
9. Villar J, Slutsky AS. The incidence of the adult respiratory distress syndrome. Am Rev Respir Dis 1989; 140: 814-6.
10. Fowler AA, Hamman RF, Good JT, Kim N, Benson B, Baird B, et al. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med 1983; 98: 593-7.
11. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA et al. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-74.
12. Left JA, Parsons PE, Day CE, Tniguchi N, Jochum M, Fritz H et al. Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis. Lancet 1993; 341: 777-80.
13. Siegel JH. Eicosanoids, cytokines and altered metabolic control in the evolution of the posttraumatic host defense failure syndromes: adult respiratory distress syndrome and multiple organ failure syndrome. I: Faist E, Meakins J, Schildberg FW, eds. Host defense dysfunction in trauma, shock and sepsis. Berlin: Springer-Verlag, 1993:199-219.
14. Hyers TM. Adult respiratory distress syndrome. Definition, risk factors, and outcome. I: Zapol W, Lemaire F, eds. Adult respiratory distress syndrome. New York: Marcel Dekker, 1991: 23-36.
15. McHugh LG, Milberg JA, Whitcomb ME, Schoene RB, Maunder RJ, Hudson LD. Recovery of function in survivors of the acute respiratory distress sydrome. Am J Respir Crit Care Med 1994; 150: 90-4.
16. Hert R, Albert RK. Sequelae of the adult respiratory distress syndrome. Thorax 1994; 49:8-13.
17. Marshall BE, Hanson CW, Frasch F, Marshall C. Role of hypoxic pulmonary vasoconstriction in pulmonary gas exchange and blood flow distribution. 2. Pathophysiology. Intensive Care Med 1994; 20: 379-89.
18. Seeger W, Stöhr G, Wolf HRD, Neuhof H. Alteration of surfactant function due to protein leakage. Special interaction with fibrin monomer. J Appl Physiol 1985; 58: 326-39.
19. Gattinoni L, Bombino M, Pelosi P, Lissoni A, Pesenti A, Fumagalli R et al. Lung structure and function in different stages of severe adult respiratory distress syndrome. JAMA 1994; 271: 1772-9.
20. Neuhof H. Actions and interactions of mediator systems and mediators in the pathogenesis of ARDS and multiorgan failure. Acta Anaesthesiol Scand 1991; 35 (suppl): 7-14.
21. Sprung CL, Schulte DR, Marcial E, Caralis PV, Gelbard MA, Arnold PE et al. Complement activation in septic shock patients. Crit Care Med 1986: 14: 525-8.
22. Deby-Dupont G, Braun M, Lamy M, Deby C, Pincemail J, Faymonville ME et al. Thromboxane and prostacyclin release in adult respiratory distress syndrome. Intensive Care 1987; 13: 167-74.
23. Rivkind AI, Siegel JH, Mamantov T, Littleton M. Respiratory burst activation and the pattern of physiologic relationships in the evolution of the fulminant posttraumatic adult respiratory distress syndrome. Circ Shock 1991; 33:48-62.
24. Cooper JA, Neuman PH, Wright SD, Malik AB Pulmonary vascular sequestration of neutrophils in endotoxemia: role of CD 18 leukocyte surface glycoprotein. Am Rev Respir Dis 1989; 139: A301.
25. Hoover RL, Karnowsky MJ, Austen KF, Corey EJ, Lewis RA. Leukotriene B4 action on endothelium mediates augmented neutrophil endothelial adhesions. Proc Natl Acad Sci USA, 1984; 81: 2191-3.
26. Vedder NB, Winn RK, Rice CL, Chi EY, Arfors K-E, Harlan JM. A monoclonal antibody to adherence promoting leukocyte glycoprotein, CD 18, reduces organ injury and improves survival from hemorrhagic shock and resuscitation in rabbits. J Clin Invest 1988; 81: 939-44.
27. Kushner I. The phenomenon of the acute phase response. Ann NY Acad Sci 1982; 389:39-48.
28. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-76.
29. Pearse DB, Wagner EM, Sylvester JT. Edema clearance in isolated sheep lungs. J Appl Physiol 1993; 74:126-32.
30. Matthay MA, Wiener-Kronish JP. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 1990; 142: 1250-7.
31. Grimbert FA. Effective pulmonary capillary pressure [editorial]. Eur Respir J 1988; 1: 297-301.
32. Cope DK, Grimbert F, Downey JM, Taylor AE. Pulmonary capillary pressure: a review. Crit Care Med 1992; 20: 1043-56.
33. Dhainant JF, Brunet F. Right ventricular performance in adult respiratory distress syndrome. Eur Respir J 1990; 3 (suppl 11): S490-5.
34. Rossaint R, Falke KJ, López F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328: 399-405.
35. Danzker DR. Oxygen transport and utilization in ARDS. Eur Respir J 1990; 3 (suppl 11): S485-9.
36. Meduri GU, Belenchia JM, Estes RJ, Wunderink R, El Torky M, Leeper KV. Fibroproliferative phase of ARDS; clinical findings and effects of corticosteroids. Chest 1991; 100:943-52.
37. Mitchell JP, Schuller D, Calandrino FS, Schuster DP. Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization. Am Rev Respir Dis 1992; 145:990-8
38. 1 in the adult respiratory distress syndrome. Am Rev Respir Dis 1989; 139: 106-10.
39. Radermacher P, Santak B, Wüst HJ, Tarnow J, Falke KJ. Prostacyclin and right ventricular function in patients with pulmonary hypertension associated with ARDS. Intensive Care Med 1990; 16: 227-32.
40. Takala J, Yalta P. Mechanical ventilation in ARDS: interaction of respiratory mechanics and gas exchange. I: Vincent JL, ed. Yearbook of intensive care and emergency medicine. Berlin: Springer-Verlag-, 1995; 15: 71-80.